
### [MONDO:0018379](http://purl.obolibrary.org/obo/MONDO_0018379)
**Label:** primary avascular necrosis

**Subclasses:** [MONDO:0012126](http://purl.obolibrary.org/obo/MONDO_0012126) (familial avascular necrosis of femoral head), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), [MONDO:0018380](http://purl.obolibrary.org/obo/MONDO_0018380) (idiopathic avascular necrosis), 

**Mapped go classes:** [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), 

**Class expressions from DL-Learner:**

- Thing 53.32%
- [GO:1905360](http://purl.obolibrary.org/obo/GO_1905360) (GTPase complex) 51.85%
- [GO:0098743](http://purl.obolibrary.org/obo/GO_0098743) (cell aggregation) 51.85%
- [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus) 51.85%
- [GO:0071772](http://purl.obolibrary.org/obo/GO_0071772) (response to BMP) 51.85%
- [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development) 51.85%
- [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation) 51.85%
- [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding) 51.85%
- [GO:0051429](http://purl.obolibrary.org/obo/GO_0051429) (corticotropin-releasing hormone receptor binding) 51.85%
- [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding) 51.85%
- [GO:0050954](http://purl.obolibrary.org/obo/GO_0050954) (sensory perception of mechanical stimulus) 51.85%
- [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development) 51.85%
- [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding) 51.85%
- [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma) 51.85%
- [GO:0036075](http://purl.obolibrary.org/obo/GO_0036075) (replacement ossification) 51.85%


